Biopharma R&D, Clinical Trials, and Biomarker Discovery Propel...

added blog Other

2025-07-15 13:45:20 - Translate

Biopharma R&D, Clinical Trials, and Biomarker Discovery Propel Red Biotechnology Growth

The global red biotechnology market was valued at USD 531.66 billion in 2024, with a projected CAGR of 10.31% anticipated from 2025 to 2034. This trajectory is being significantly influenced by key countries such as the United States, China, Germany, and Japan, each contributing to global revenue through strategic R&D initiatives, robust local manufacturing bases, and well-established...

0 Comments 0 Shares 45 Views 0 Reviews